Treatment of skin diseases of various origins with a multi-action drug combination

Forty-three patients with skin diseases of poorly defined natures, often related to lengthy periods of hospitalization, were treated for 10 days with a combination of three creams, the active ingredients of which were beclomethasone dipropionate (0.025%), ketoconazole (2%) and sodium fusidate (2%),...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC). - 1995. - 4(1985), 5 vom: 23., Seite 296-9
1. Verfasser: Scremin, S (VerfasserIn)
Format: Aufsatz
Sprache:English
Veröffentlicht: 1985
Zugriff auf das übergeordnete Werk:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)
Schlagworte:Journal Article Drug Combinations Fusidic Acid 59XE10C19C Beclomethasone KGZ1SLC28Z Ketoconazole R9400W927I
LEADER 01000naa a22002652 4500
001 NLM040515672
003 DE-627
005 20231221151248.0
007 tu
008 231221s1985 xx ||||| 00| ||eng c
028 5 2 |a pubmed24n0135.xml 
035 |a (DE-627)NLM040515672 
035 |a (NLM)4070322 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Scremin, S  |e verfasserin  |4 aut 
245 1 0 |a Treatment of skin diseases of various origins with a multi-action drug combination 
264 1 |c 1985 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 30.12.1985 
500 |a Date Revised 21.11.2013 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Forty-three patients with skin diseases of poorly defined natures, often related to lengthy periods of hospitalization, were treated for 10 days with a combination of three creams, the active ingredients of which were beclomethasone dipropionate (0.025%), ketoconazole (2%) and sodium fusidate (2%), respectively. Positive results were obtained in 81.4% of the patients treated with good remission of symptoms and good healing of initial lesions. Local tolerance was excellent, and no adverse effects were observed 
650 4 |a Journal Article 
650 7 |a Drug Combinations  |2 NLM 
650 7 |a Fusidic Acid  |2 NLM 
650 7 |a 59XE10C19C  |2 NLM 
650 7 |a Beclomethasone  |2 NLM 
650 7 |a KGZ1SLC28Z  |2 NLM 
650 7 |a Ketoconazole  |2 NLM 
650 7 |a R9400W927I  |2 NLM 
773 0 8 |i Enthalten in  |t Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)  |d 1995  |g 4(1985), 5 vom: 23., Seite 296-9  |w (DE-627)NLM023961570 
773 1 8 |g volume:4  |g year:1985  |g number:5  |g day:23  |g pages:296-9 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_22 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_121 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 4  |j 1985  |e 5  |b 23  |h 296-9